$3.7 million trial uses genes to balance risks, benefits of blood thinner

A five-year, $3.7 million clinical trial will investigate how to balance the benefits and risks of warfarin, a drug that helps prevent potentially deadly blood clots. The multicenter study, led by researchers at Washington University School of Medicine in St. Louis, will evaluate customized warfarin dosage based on patient genetics and will test which range of blood clotting is optimal in orthopedic patients.

Orthopaedic surgeons preserve hip joint in young adult patients

Surgeons cut and reposition hip bones to reduce pain.When an older person has a hip problem, surgeons often replace the damaged hip with an artificial one. But that’s not a good option for someone in their 20s or 30s, so orthopaedic surgeons at the School of Medicine are repairing damage to the hip to prevent arthritis without having to replace the hip joint.